Response-Adapted Strategy in the Treatment of Primary Mediastinal Large B-Cell Lymphoma: Results of a Prospective Single-Center Clinical Trial

BACKGROUND. Up to now, neither the optimal treatment regimen for primary mediastinal large B-cell lymphoma (PMBCL), nor poor/favorable prognostic factors for risk stratification at the disease onset have been found. The prognosis of PMBCL is determined by the depth of metabolic response by the time...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Yana Konstantinovna Mangasarova, R. R. Abdurashidova, A. U. Magomedova, O. V. Margolin, E. S. Nesterova, L. G. Gorenkova, M. O. Bagova, E. A. Fastova, D. S. Belkina, A. M. Kovrigina, N. G. Gabeeva, D. A. Koroleva, S. K. Kravchenko, Yu. A. Chabaeva, E. E. Zvonkov
Format:	Artigo
Sprog:	Russo
Udgivet:	Practical Medicine Publishing House 2024-10-01
Serier:	Клиническая онкогематология
Fag:	primary mediastinal (thymic) large b-cell lymphoma da-epoch-r high-dose chemotherapy auto-hsct immune checkpoint inhibitors response-adapted strategy of therapy pregnancy
Online adgang:	https://bloodjournal.ru/index.php/coh/article/view/100
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!